Meprobamate
Established medicineAlso known as Equagesic, Equanil, MB-TAB, Micrainin+5 more
Equagesic, Equanil, MB-TAB, Micrainin, Miltown, PMB, Meprobamat, Meprobamato, Meprobamatum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Drug Safety Update: Meprobamate: licence to be cancelled
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Contains public sector information from the Medicines and Healthcare products Regulatory Agency (MHRA) licensed under the Open Government Licence (OGL v3).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Regulatory event sources are credited in the Regulatory Timeline above.